SCHEMBL25825392

SCHEMBL25825392

O=C(Nc1ccc(Nc2ccccc2)cc1)c1ccc(Nc2ccnc3ccc(F)cc23)cn1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DNMT1 P26358 5/20 0.54
DNMT3A Q9Y6K1 4/20 0.54
DNMT3L Q9UJW3 1/20 0.54
CCNC P24863 1/20 0.51
CDK8 P49336 1/20 0.51
KMT2A Q03164 4/20 0.48
USP2 O75604 2/20 0.48
MAPT P10636 2/20 0.48
AURKA O14965 5/20 0.47
AURKB Q96GD4 5/20 0.47
HDAC3 O15379 2/20 0.47
NCOR1 O75376 1/20 0.47
MEN1 O00255 2/20 0.46
NPC1 O15118 2/20 0.46
RAB9A P51151 2/20 0.46
POLB P06746 2/20 0.46
MAPKAPK2 P49137 1/20 0.46
GAK O14976 1/20 0.46
ACHE P22303 1/20 0.46
HDAC1 Q13547 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19151650 0.92 KMT2A (0.57) DNMT1DNMT3ADNMT3LCCNCCDK8
SCHEMBL30180650 0.92 KMT2A (0.57) DNMT1DNMT3ADNMT3LCCNCCDK8
SCHEMBL23999712 0.89 DNMT1 (0.69) DNMT1DNMT3ADNMT3LCCNCCDK8
SCHEMBL24003819 0.89 DNMT1 (0.53) DNMT1DNMT3ADNMT3LCCNCCDK8
SCHEMBL25825387 0.88 DNMT1 (0.58) DNMT1DNMT3ADNMT3LKMT2AUSP2
SCHEMBL25825389 0.87 DNMT1 (0.56) DNMT1DNMT3ADNMT3LKMT2AUSP2
SCHEMBL24005986 0.86 DNMT1 (0.74) DNMT1DNMT3ADNMT3LCCNCCDK8
SCHEMBL25826586 0.86 DNMT1 (0.51) DNMT1DNMT3ADNMT3LCCNCCDK8
SCHEMBL25825391 0.86 DNMT1 (0.51) DNMT1DNMT3ADNMT3LKMT2AUSP2
SCHEMBL25820540 0.85 DNMT1 (0.53) DNMT1DNMT3ADNMT3LCCNCCDK8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230183226-A1 AKT3 MODULATORS Georgiamune Inc. 2023-06-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230183226-A1 AKT3 MODULATORS AKT3, AKT2, MTOR DNMT1 4785/4885DNMT3A 4693/4885DNMT3L 4461/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.